[
    "{\"step_by_step_thinking\": \"The document [0] clearly states that expert breast pathology assessments continue to be necessary in the management of ductal carcinoma in situ (DCIS). This is due to the significant variability in pathologic reporting of DCIS and the impact of expert breast pathology on risk assessment and treatment.\", \"answer_choice\": \"A\"}"
]